Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Genus Oncology, LLC
ClinicalTrials.gov Identifier:
NCT01279603
First received: January 11, 2011
Last updated: September 18, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)